首页 | 本学科首页   官方微博 | 高级检索  
检索        

纳米羟基磷灰石/聚酰胺在脊髓型颈椎病椎体次全切减压融合术中的应用
引用本文:杨朝垒,王利民,谭洪宇,王卫东,廖文胜,鲍恒,刘屹林.纳米羟基磷灰石/聚酰胺在脊髓型颈椎病椎体次全切减压融合术中的应用[J].复旦学报(医学版),2011,38(1):14-17.
作者姓名:杨朝垒  王利民  谭洪宇  王卫东  廖文胜  鲍恒  刘屹林
作者单位:郑州大学第一附属医院骨科,郑州450052
基金项目:国家科技支撑计划课题(2007BAE13B00)
摘    要: 目的 探讨纳米羟基磷灰石/聚酰胺(n-HA/PA66)在脊髓型颈椎病椎体次全切减压融合术中的应用效果。方法 对30例脊髓型颈椎病患者均行颈椎前路椎体次全切n-HA/PA66植入钛板内固定术,对其疗效及融合情况进行评价。结果 30例患者均成功完成手术并获得随访,随访时间9~17个月,平均12.6个月。所有患者神经症状均明显改善,植入物未引起过敏及毒性反应,颈椎生理曲度、椎间高度有良好的恢复和维持,术后6~8个月时获得植骨融合,n-HA/PA66人工椎体后缘存在不同程度的异位骨化。结论 n-HA/PA66人工椎体作为颈椎前路手术植骨材料融合率高,可以有效保持颈椎生理曲度及椎间高度。长期效果有待进一步观察。

关 键 词:颈椎病  羟基磷灰石  聚酰胺  椎体次全切除  植骨融合
收稿时间:2010-6-10

Application of n-HA/PA66 in anterior cervical subtotal corpectomy and fusion for treatment of cervical spondylotic myelopathy
YANG Chao-lei,WANG Li-min,TAN Hong-yu,WANG Wei-dong,LIAO Wen-sheng,BAO Heng,LIU Yi-lin.Application of n-HA/PA66 in anterior cervical subtotal corpectomy and fusion for treatment of cervical spondylotic myelopathy[J].Fudan University Journal of Medical Sciences,2011,38(1):14-17.
Authors:YANG Chao-lei  WANG Li-min  TAN Hong-yu  WANG Wei-dong  LIAO Wen-sheng  BAO Heng  LIU Yi-lin
Institution:Department of Orthopedics, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China
Abstract:Objective To discuss the application effect of nano-hydroxyapatite and polyamide composite(n-HA/PA66) in anterior cervical subtotal corpectomy and fusion with plate for the treatment of cervical spondylotic myelopathy. Methods Thirty patients with cervical spondylotic myelopathy were treated with anterior cervical subtotal corpectomy,in which n-HA/PA66 was grafted and platted for the decompression and fusion.The clinical results and graft fusion were evaluated after the operation. Results All patients were ...
Keywords:cervical spondylosis  nano-hydroxyapatite  polyamide  cervical subtotal corpectomy  graft fusion  
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《复旦学报(医学版)》浏览原始摘要信息
点击此处可从《复旦学报(医学版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号